Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 0.06% |
$11,460
$11.46 p/Share
|
Mar 29
2021 |
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$29,960
$14.98 p/Share
|
Mar 29
2021 |
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$29,960
$14.98 p/Share
|
Mar 29
2021 |
WMPN
|
Jill Mc Menamin Ross
EVP & CRCO |
BUY
Open market or private purchase
|
Indirect | 4,368 Added 49.72% |
$50,014
$11.45 p/Share
|
Mar 29
2021 |
AGRX
|
Jason Butch
Principal Accounting Officer |
BUY
Open market or private purchase
|
Direct | 1,358 Added 6.36% |
$2,702
$1.99 p/Share
|
Mar 29
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 28 Added 0.21% |
$41,338
$1476.34 p/Share
|
Mar 29
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.25% |
$4,429
$1476.34 p/Share
|
Mar 29
2021 |
PFSI
|
Mfn Partners, LP
Director |
BUY
Open market or private purchase
|
Direct | 94,106 Added 5.87% |
$6,060,427
$64.4 p/Share
|
Mar 29
2021 |
GMS
|
Coliseum Capital Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 80,000 Added 1.74% |
$3,184,800
$39.81 p/Share
|
Mar 29
2021 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.18% |
$1,782
$2.64 p/Share
|
Mar 29
2021 |
PFSI
|
Farhad Nanji
Director |
BUY
Open market or private purchase
|
Indirect | 94,106 Added 5.87% |
$6,060,427
$64.4 p/Share
|
Mar 29
2021 |
TSI
|
Laird Landmann
PORTFOLIO MANAGER |
BUY
Open market or private purchase
|
Direct | 3,200 Added 0.76% |
$18,144
$5.67 p/Share
|
Mar 29
2021 |
FXNC
|
Gerald F Smith Jr
Director |
BUY
Open market or private purchase
|
Direct | 4,255 Added 10.21% |
$76,718
$18.03 p/Share
|
Mar 29
2021 |
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 1.23% |
$1,342
$8.95 p/Share
|
Mar 29
2021 |
TURN
|
Alicia M Gift
Treasurer, Secretary |
BUY
Open market or private purchase
|
Direct | 500 Added 2.15% |
$3,675
$7.35 p/Share
|
Mar 29
2021 |
TAYD
|
Timothy John Sopko
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 1,053 Added 25.98% |
$11,520
$10.94 p/Share
|
Mar 29
2021 |
CYTH
|
Markus Sieger
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 12.88% |
$81,000
$8.1 p/Share
|
Mar 29
2021 |
CYTH
|
Joshua M Fine
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 50 Added 0.29% |
$370
$7.4 p/Share
|
Mar 29
2021 |
CYTH
|
Sharon Hemond Hrynkow
Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct | 1,000 Added 5.17% |
$7,460
$7.46 p/Share
|
Mar 29
2021 |
CYTH
|
Francis Patrick Ostronic
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 4.65% |
$22,500
$7.5 p/Share
|
Mar 29
2021 |
CYTH
|
Jeffrey Tate
Chief Operating Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 6.86% |
$15,000
$7.5 p/Share
|
Mar 29
2021 |
SEMR
|
Roman Simonov
Director |
BUY
Open market or private purchase
|
Direct | 13,000 Added 50.0% |
$182,000
$14.0 p/Share
|
Mar 29
2021 |
TRIP
|
Certares Ltrip LLC |
BUY
Open market or private purchase
|
Indirect | 1,713,859 Added 50.0% |
-
|
Mar 29
2021 |
BWFG
|
James M Garnett Jr
Director |
BUY
Open market or private purchase
|
Direct | 94 Added 50.0% |
$2,491
$26.5 p/Share
|
Mar 29
2021 |
BWFG
|
Lawrence B Seidman
Director |
BUY
Open market or private purchase
|
Direct | 139 Added 50.0% |
$3,684
$26.5 p/Share
|
Mar 29
2021 |
MTEM
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct | 80,000 Added 0.98% |
$916,000
$11.45 p/Share
|
Mar 29
2021 |
GTIM
|
Charles E Jobson |
BUY
Open market or private purchase
|
Indirect | 6,189 Added 1.84% |
$24,756
$4.0 p/Share
|
Mar 29
2021 |
BNKL
|
Joseph R Martin
Director |
BUY
Open market or private purchase
|
Direct | 26,430 Added 50.0% |
-
|
Mar 29
2021 |
BNKL
|
Audrey Thevenon
Director |
BUY
Open market or private purchase
|
Direct | 26,430 Added 50.0% |
-
|
Mar 29
2021 |
BNKL
|
Charles Matine
Director |
BUY
Open market or private purchase
|
Direct | 26,430 Added 50.0% |
-
|
Mar 29
2021 |
BNKL
|
Peter Gerald Malone
Director |
BUY
Open market or private purchase
|
Direct | 26,430 Added 50.0% |
-
|
Mar 29
2021 |
TIPLX
|
Jason Emala
Secretary |
BUY
Open market or private purchase
|
Indirect | 1,651 Added 3.2% |
$49,992
$30.28 p/Share
|
Mar 29
2021 |
CMPI
|
Arthur M Krieg
Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct | 33,220 Added 4.09% |
$371,067
$11.17 p/Share
|
Mar 29
2021 |
IMH
|
Rhp Trust, Dated May 31, 2011
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 18,050 Added 0.53% |
$36,280
$2.01 p/Share
|
Mar 29
2021 |
IMH
|
Richard H. Pickup
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 18,050 Added 0.53% |
$36,280
$2.01 p/Share
|
Mar 29
2021 |
BANX
|
Michael Van Praag
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 33.33% |
$99,250
$19.85 p/Share
|
Mar 29
2021 |
DFCO
|
Brian Bonar
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 4,000 Added 0.07% |
$1,480
$0.37 p/Share
|
Mar 29
2021 |
DSE
|
Css LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,960 Added 0.41% |
$14,269
$7.28 p/Share
|
Mar 29
2021 |
HOFT
|
W Christopher Beeler Jr
Director |
BUY
Open market or private purchase
|
Direct | 18 Added 0.04% |
-
|
Mar 29
2021 |
PUBM
|
Cnh Capital CO LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 2.95% |
$920,000
$46.0 p/Share
|
Mar 29
2021 |
DUSYF
|
See Ming Ong
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 0.56% |
$4,750
$0.95 p/Share
|
Mar 27
2021 |
FMBM
|
Larry A Caplinger
Director |
BUY
Open market or private purchase
|
Direct | 975 Added 47.89% |
$25,857
$26.52 p/Share
|
Mar 26
2021 |
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 1.24% |
$1,334
$8.89 p/Share
|
Mar 26
2021 |
PFSI
|
Mfn Partners, LP
Director |
BUY
Open market or private purchase
|
Direct | 129,062 Added 8.36% |
$8,356,764
$64.75 p/Share
|
Mar 26
2021 |
PFSI
|
Farhad Nanji
Director |
BUY
Open market or private purchase
|
Indirect | 129,062 Added 8.36% |
$8,356,764
$64.75 p/Share
|
Mar 26
2021 |
EPZM
|
David M Mott
Director |
BUY
Open market or private purchase
|
Direct | 34,486 Added 18.6% |
$272,095
$7.89 p/Share
|
Mar 26
2021 |
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.41% |
$8,765
$17.53 p/Share
|
Mar 26
2021 |
CMPI
|
Arthur M Krieg
Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct | 3,484 Added 0.46% |
$42,331
$12.15 p/Share
|
Mar 26
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 28 Added 0.21% |
$44,184
$1578.0 p/Share
|
Mar 26
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.25% |
$4,734
$1578.0 p/Share
|
Mar 26
2021 |